BOYALIFE BIOPHARMA LTD

Overview

BOYALIFE BIOPHARMA LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering HUMAN UMBILICAL CORD WHARTONS JELLY MESENCHYMAL STEM CELL EXOSOMES.

API / Drug Master Files

BOYALIFE BIOPHARMA LTD holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• HUMAN UMBILICAL CORD WHARTONS JELLY MESENCHYMAL STEM CELL EXOSOMESActive2024-12-01

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BOYALIFE BIOPHARMA LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.